[英]HTML file parse section to csv
我是 Python 的新手。 我試圖從網頁 ( https://www.dropbox.com/s/uka24w7o5006ole/transcript-86-855.html?dl=0 ) 的高管(在頂部提到)那里得到所有答案。 這個網頁位於我的硬盤上(所以沒有網址)。
所以我的最終結果是:
Column 1
All executives
Column 2
all the answers
答案應該只來自“問答部分”。
我嘗試的是以下內容:
from bs4 import BeautifulSoup
import requests
with open('transcript-86-855.html') as html_file:
soup=BeautifulSoup(html_file, 'lxml')
article_qanda = soup.find('DIV', id='article_qanda'
有人可以幫我嗎?
如果我理解正確,你想打印兩列,一列是 Name(在這種情況下Dror Ben Asher
),另一列是他的答案。
例如:
import textwrap
from bs4 import BeautifulSoup
with open('page.html', 'r') as f_in:
soup = BeautifulSoup(f_in.read(), 'html.parser')
print('{:<30} {:<70}'.format('Name', 'Answer'))
print('-' * 101)
for answer in soup.select('p:contains("Question-and-Answer Session") ~ strong:contains("Dror Ben Asher") + p'):
txt = answer.get_text(strip=True)
s = answer.find_next_sibling()
while s:
if s.name == 'strong' or s.find('strong'):
break
if s.name == 'p':
txt += ' ' + s.get_text(strip=True)
s = s.find_next_sibling()
txt = ('\n' + ' '*31).join(textwrap.wrap(txt))
print('{:<30} {:<70}'.format('Dror Ben Asher - CEO', txt))
print()
印刷:
Name Answer
-----------------------------------------------------------------------------------------------------
Dror Ben Asher - CEO Thank you, Scott. Its a very good question indeed in January we
announced a new amendment and that amendment includes anti-TNF
patients some of them not all of them, those who qualify. And we are
talking about anti-TNF failures to be clear and only Remicade and
Humira. The idea here was to increase very significantly the patients
pooled of those potentially eligible for the study thus expediting
recruitment. Did I answer your question?
Dror Ben Asher - CEO Right, this is one of most important tasks; right now the most
important item here is the divestment of non-core assets. All other
non-core assets, the non-core assets are those that are not within our
therapeutic focus of GI and inflammation. And those are specifically
RHB-103 RIZAPORT for migraine and RHB-101 which is a cardio drug.
RHB-101 is a legacy drug, we have recently announced last month, we
announced that we are in discussions for both of these product for
out-licensing, which we hope to complete in the first half of 2015. So
this is the highest priority, obviously discussion on other product,
but Redhill is in the fortunate position that we are able to complete
our Phase III studies with our existing results, resources and as time
goes by obviously the value of the assets keeps going up. So we are in
no rush to out-license everything else and so there is obviously in
track.
...and so on.
聲明:本站的技術帖子網頁,遵循CC BY-SA 4.0協議,如果您需要轉載,請注明本站網址或者原文地址。任何問題請咨詢:yoyou2525@163.com.